$2.94
-0.0598[-1.99%]
At close: May 23
$2.94
0[0.00%]
After Hours: 4:18PM EDT
Innate Pharma
(NASDAQ:IPHA)Innate Pharma Stock (NASDAQ:IPHA), Quotes and News Summary
Innate Pharma Stock (NASDAQ: IPHA) stock price, news, charts, stock research, profile.
| Open | $3.048 |
| Close | $2.960 |
| Volume / Avg. | 23.570K / 9.321K |
| Day Range | 2.600 - 3.048 |
| 52 Wk Range | 1.810 - 3.570 |
| Market Cap | $237.675M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 64 |
| Short Interest | - |
| Days to Cover | 12.94 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Innate Pharma (IPHA) stock?
You can purchase shares of Innate Pharma (NASDAQ: IPHA) through any online brokerage.
Who are Innate Pharma's (IPHA) competitors?
Other companies in Innate Pharma’s space includes: Adaptimmune Therapeutics (NASDAQ:ADAP), Agenus (NASDAQ:AGEN), Monte Rosa Therapeutics (NASDAQ:GLUE), Genfit (NASDAQ:GNFT) and Design Therapeutics (NASDAQ:DSGN).
What is the target price for Innate Pharma (IPHA) stock?
The latest price target for Innate Pharma (NASDAQ: IPHA) was reported by HC Wainwright & Co. on Wednesday, May 15, 2024. The analyst firm set a price target for 11.50 expecting IPHA to rise to within 12 months (a possible 291.16% upside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Innate Pharma (IPHA)?
The stock price for Innate Pharma (NASDAQ: IPHA) is $2.94 last updated Today at May 23, 2024 at 4:18 PM EDT.
Does Innate Pharma (IPHA) pay a dividend?
There are no upcoming dividends for Innate Pharma.
When is Innate Pharma (NASDAQ:IPHA) reporting earnings?
Innate Pharma’s FY earnings are confirmed for Thursday, March 21, 2024.
Is Innate Pharma (IPHA) going to split?
There is no upcoming split for Innate Pharma.
What sector and industry does Innate Pharma (IPHA) operate in?
Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.